JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 19, 2007; DOI: 10.1124/jpet.107.122093


0022-3565/07/3221-316-323$20.00
JPET 322:316-323, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.122093v1
322/1/316    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Machová, E.
Right arrow Articles by Dolezal, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Machová, E.
Right arrow Articles by Dolezal, V.

NEUROPHARMACOLOGY

Wash-Resistantly Bound Xanomeline Inhibits Acetylcholine Release by Persistent Activation of Presynaptic M2 and M4 Muscarinic Receptors in Rat Brain

E. Machová, J. Jakubík, E. E. El-Fakahany, and V. Dolezal

Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic (E.M., J.J., V.D.); and Department of Psychiatry, University of Minnesota Medical School, Minneapolis, Minnesota (E.E.E.)

We studied the effects of 3-[3-hexyloxy-1,2,5-thiadiazo-4-yl]-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) wash-resistant binding on presynaptic muscarinic regulation of electrically evoked [3H]acetylcholine (ACh) release from rat brain slices. In both cortical and striatal tissues that possess M2 and M4 autoreceptors, respectively, immediate application of 10 µM xanomeline had no effect on evoked [3H]ACh release or its inhibition by 10 µM carbachol. In contrast, preincubation with 1, 10, or 100 µM xanomeline for 15 min decreased evoked release of ACh measured after 53 min of washing in xanomeline-free medium in a concentration-dependent manner. The maximal inhibitory effect equaled the immediate effect of the muscarinic full agonist carbachol, and it was completely (at 1 and 10 µM xanomeline) or partially (at 100 µM xanomeline) blocked by 1 µM N-methylscopolamine. Neither presence of N-methylscopolamine during 100 µM xanomeline treatment nor previous irreversible inactivation of the classical receptor binding site using propylbenzylcholine mustard in cortical slices prevented the inhibitory effect of wash-resistantly bound xanomeline. Treatment of cortical slices with xanomeline slightly decreased the number of muscarinic binding sites, and it markedly decreased affinity for N-methylscopolamine. When applied as in acetylcholine release experiments, xanomeline did not impair presynaptic {alpha}2-adrenoceptor-mediated regulation of noradrenaline release. The functional studies in brain tissue reported in this work demonstrate that xanomeline can function as a wash-resistant agonist of native presynaptic muscarinic M2 and M4 receptors with both competitive and allosteric components of action.


Received March 1, 2007; accepted April 18, 2007.

Address correspondence to: Dr. Vladimír Dolezal, Department of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Vídenská 1083, 14220 Prague, Czech Republic. E-mail: dolezal{at}biomed.cas.cz




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
T. P. Kenakin
Seven Transmembrane Receptors as Nature's Prototype Allosteric Protein: De-emphasizing the Geography of Binding
Mol. Pharmacol., September 1, 2008; 74(3): 541 - 543.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.